Catalyst Wire Dossier Catalyst Wire Dossier

GTx-024

· GTx, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for GTx-024, covering 2013-02-21 to 2021-02-01. Get the full timeline:

Most recent: Clinical Trial Update: GTx-024 as a Treatment for Stress Urinary Incontinence in Women [Phase 2]

See pricing